James Michael Orcutt

Statistics

Publications

Citations

641

H-Index

Active since

2019

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

James Michael Orcutt is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, cancer immunotherapy, and molecular oncology.

Publications per year

2019–2019

Publications

First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

Neal Ready, Matthew D. Hellmann, Mark M. Awad et al. · Journal of Clinical Oncology · 2019 · 596 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Samuel A. Jacobs, André Robidoux, Jame Abraham et al. · Breast Cancer Research · 2019 · 45 citations · Full text

Medicine, Oncology, Pharmacology +15

1–2 of 2